Ignite Creation Date:
2024-05-05 @ 5:20 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00430547
Status:
COMPLETED
Last Update Posted:
2007-02-02
First Post:
2007-02-01
Brief Title:
Thyroid-Associated Ophthalmopathy Subtypes and Orbital Antibodies
Sponsor:
Barwon Health
Organization:
Barwon Health
Study Overview
Official Title:
Thyroid-Associated Ophthalmopathy Subtypes and Orbital Antibodies
Status:
COMPLETED
Status Verified Date:
2003-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine whether radioactive iodine as compared to anti-thyroid medications is a risk factor for the development or progression of thyroid-associated ophthalmopathy in patients with hyperthyroidism due to Graves disease The other aim of this study is to determine the incidence of the various ophthalmopathy subtypes and the utility of orbital antibodies in the diagnosis classification and monitoring of patients with thyroid-associated ophthalmopathy
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None